Balance Sheet

Accounts Payables Accumulated Expenses Assets Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Dividends payables Finished Goods Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Abvc Biopharma (ABVC) Work In Process (2018 - 2019)

Historic Work In Process for Abvc Biopharma (ABVC) over the last 2 years, with Q4 2019 value amounting to $20676.0.

Abvc Biopharma's Work In Process rose 213.9% to $20676.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $20676.0, marking a year-over-year increase of 213.9%. This contributed to the annual value of $20676.0 for FY2019, which is 213.9% up from last year.
Abvc Biopharma's Work In Process amounted to $20676.0 in Q4 2019, which was up 213.9% from $19937.0 recorded in Q3 2019.
Abvc Biopharma's 5-year Work In Process high stood at $20676.0 for Q4 2019, and its period low was $19933.0 during Q2 2019.